[Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children]. [electronic resource]
Producer: 20111014Description: S43-7 p. digitalISSN:- 1524-4733
- Acetates -- economics
- Adolescent
- Adrenal Cortex Hormones -- economics
- Adrenergic beta-2 Receptor Agonists -- economics
- Albuterol -- analogs & derivatives
- Androstadienes -- economics
- Anti-Asthmatic Agents -- economics
- Asthma -- diagnosis
- Child
- Cost Savings
- Cost-Benefit Analysis
- Cyclopropanes
- Drug Combinations
- Drug Costs
- Fluticasone-Salmeterol Drug Combination
- Hospitalization -- economics
- Humans
- Mexico
- Models, Economic
- National Health Programs -- economics
- Outcome and Process Assessment, Health Care -- economics
- Prospective Studies
- Quinolines -- economics
- Sulfides
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.